2007/2008 Pharmaceutical R&D Factbook Published by CMR International is Now Available

Research of the Top 20 Companies Investing in R&D Shows Revenue Derived from New Products Accounted for Just 16% of Total Revenue in 2006

PHILADELPHIA and LONDON, Sept. 25 /Xinhua-PRNewswire/ -- The Centre for Medicines Research International Ltd. (CMR), a Thomson business, today announced it has published the CMR 2007 International Pharmaceutical R&D Factbook, an indispensable reference and business planning tool for decision makers in pharmaceutical R&D, corporate finance, business strategy, marketing planning and corporate communications. The Factbook offers a comprehensive and up-to-date overview of emerging trends in worldwide pharmaceutical R&D, enabling users to include data in presentations and reports.

CMR's research of the top 20 companies investing in R&D shows that revenue derived from new products (those launched within the last five years) accounted for just 16% of total revenue in 2006, continuing the industry's potential exposure to patent expiry. And although the cost of R&D continues to rise, there's no sign of a sustained upturn in the number of new products reaching the market. Also noteworthy this year is the continuing expansion of clinical development in traditionally non-core countries (that is, countries other than the eight core countries: Canada, France, Germany, Italy, Japan, Spain, UK and US). In 2005, nearly 50% of patients recruited to clinical trials came from these non-core regions.

"The CMR Factbook provides valuable insight into R&D activity within the pharmaceutical industry," says Peter Joshua, vice president and general manager, CMR International. "Our research can help users make informed decisions that can reduce development times, improve efficiency, implement more accurate performance target-setting and predictive modeling, and gauge internal performance against competitors."

Underlying data found in the Factbook are exclusively from primary sources and include all major pharmaceutical companies, which account for approximately 80% of the industry's global R&D expenditure. The Factbook condenses the latest learnings and analysis from CMR's uniquely comprehensive and robust industry-wide databases. Each finding is presented in a clear, easily-understood chart, accompanied by a succinct commentary highlighting the key messages together with an explanation of the methodology used and the definitions applied.

The CMR International 2007 Pharmaceutical R&D Factbook is available as a hard copy report, or in single-user or enterprise-wide electronic format supplied on CD. The CD contains the Factbook as both a PDF document and in PowerPoint format, consisting of full-screen versions of each of the charts with commentary as speaker's notes. The enterprise-wide license equips users to distribute the complete Factbook throughout an organization and its wholly-owned subsidiaries.

About The Thomson Corporation

The Thomson Corporation (http://www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development -- from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at http://scientific.thomson.com.